VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
2.780
+0.056 (2.06%)
Apr 28, 2026, 4:00 PM EDT - Market closed
VolitionRx Employees
VolitionRx had 75 employees as of December 31, 2025. The number of employees decreased by 10 or -11.76% compared to the previous year.
Employees
75
Change (1Y)
-10
Growth (1Y)
-11.76%
Revenue / Employee
$23,032
Profits / Employee
-$311,427
Market Cap
22.03M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| TELA Bio | 209 |
| Myomo | 195 |
| Cytosorbents | 129 |
| IRIDEX | 93 |
| Lifeward | 81 |
| Adagio Medical Holdings | 80 |
| Picard Medical | 75 |
| Pulsenmore | 71 |
VNRX News
- 5 days ago - VolitionRx Announces Acceptance of Compliance Plan by NYSE American - PRNewsWire
- 8 days ago - Volition Launches rNuQ™ Webshop Broadening Product Range - PRNewsWire
- 27 days ago - VolitionRx Earnings Call Transcript: Q4 2025 - Transcripts
- 4 weeks ago - VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update - PRNewsWire
- 4 weeks ago - VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium - PRNewsWire
- 4 weeks ago - Volition Announces Mayo Clinic Study Demonstrates Nu.Q® Concentrations are Elevated in Trauma Patients - PRNewsWire
- 4 weeks ago - Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference - PRNewsWire
- 4 weeks ago - VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update - PRNewsWire